Document Detail

10 Low doses of trilostane fail to induce abortion during early gestation in mice and ewes.
MedLine Citation:
PMID:  18593450     Owner:  NLM     Status:  In-Data-Review    
Problem: Progesterone plays a central role during the maintenance of pregnancy. Our study aims to develop two hypoprogesteronic animal models using the 3beta-HSD inhibitor trilostane during early pregnancy. Material and Methods: Trilostane or vehicle was injected s.c. in DBA/2J-CBA/J female mice (4.5-8.5 dpc) or in ewes (5-16 day of pregnancy). Progesterone serum levels were assayed (mouse: 13.5 dpc; ewe: day 16). The resorption rate (RR), number of implantation sites (IS, mouse) or development of the conceptus (sheep) were analyzed. Results: Between trilostane-treated or control females progesterone levels did not differ in the mouse but, as expected, progesterone did not rise in the sheep model. Nevertheless, ovine conceptus development was not morphologically affected nor IS or RR in the mouse model. Conclusions: our data suggest that trilostane dose was insufficient to affect the reproductive success in our animal models. A more thorough analysis is currently undertaken in order to better characterize the phenotypes.
Me Solano; V Parker; S Camous; O Sandra; Aj Douglas; Pc Arck
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of reproductive immunology (New York, N.Y. : 1989)     Volume:  60     ISSN:  1046-7408     ISO Abbreviation:  Am. J. Reprod. Immunol.     Publication Date:  2008 Jul 
Date Detail:
Created Date:  2008-07-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8912860     Medline TA:  Am J Reprod Immunol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  88-9     Citation Subset:  IM    
Charité, University Medicine Berlin, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Identifying the receptor-binding part of PIBF.
Next Document:  The complement component C1q: A novel angiogenic factor?